New nanomedicine-based gel from BITS Pilani shows encouraging preclinical results for rheumatoid arthritis
Laboratory and preclinical studies showed that the developed nanoparticle system demonstrated enhanced drug uptake at the targeted site, and reduced joint inflammation and swelling.
Researchers at BITS Pilani have developed a smart nanomedicine-based topical gel that demonstrated encouraging outcomes in preclinical studies for the treatment of rheumatoid arthritis. They plan to further validate the formulation through advanced preclinical safety studies, followed by clinical trials to evaluate its efficacy in human patients.
Challenges of Rheumatoid Arthritis
A chronic autoimmune disorder affecting many worldwide, rheumatoid arthritis causes persistent joint pain, swelling, stiffness and gradual joint damage. The condition often requires long-term medication, which can lead to systemic side effects.
About BITS Pilani
BITS Pilani (Birla Institute of Technology & Science) is a premier private deemed university in India (est. 1964) renowned for high-quality education in engineering, sciences, and management. It is ranked 11th in India (NIRF 2025) and operates top-tier, innovation-focused campuses with high placement rates, supported by a vast, influential alumni network.
Its flagship campus is located in Pilani, Rajasthan, with other campuses situated in Goa, Hyderabad, and Dubai.
